Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antiretrovirals
Study data from S.D. Makombe and colleagues update understanding of antiretrovirals
May 18th, 2008
New research, 'Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi,' is the subject of a report. According to recent research from Lilongwe, Malawi, "PROBLEM: As national antiretroviral treatment (ART) programmes scale-up, it is essential that information is complete, timely and accurate for site monitoring and national planning. The accuracy and completeness of reports independently compiled by ART facilities, however, is often not known." "APPROACH: This study assessed the quality of quarterly aggregate summary data for April to June 2006 compiled and reported by ART facilities ('site report') as compared to the 'gold standard'...
Source: Medical Letter on the CDC & FDA (2008-05-18)
|
